Fortress Biotech to Participate in the Alliance Global Partners' (A.G.P.) Virtual Healthcare Company Showcase

Company Overview - Fortress Biotech, Inc. is an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings, and dividend and royalty revenue [3] - The company has seven marketed prescription pharmaceutical products and over 20 programs in development across various therapeutic areas including oncology, dermatology, and rare diseases [3] - Fortress has established partnerships with leading academic research institutions and biopharmaceutical companies such as AstraZeneca, City of Hope, Fred Hutchinson Cancer Center, Nationwide Children's Hospital, and Sentynl to maximize opportunities [3] Upcoming Events - Lindsay A. Rosenwald, M.D., Chairman, President, and CEO of Fortress, will participate in a fireside chat at the Alliance Global Partners' Virtual Healthcare Company Showcase on May 21, 2024, at 4:20 p.m. ET [1] - A replay of the fireside chat will be available on Fortress' website for approximately 30 days following the meeting [2]